NEUTROGUARD study: Phase III clinical study of DEFENCATH for prevention of CLABSI in adults on TPN via central venous catheter.
We look forward to sharing additional Phase 1/2 data next week at the Muscular Dystrophy Association's annual meeting and ...
Please turn to Slide 2, where you will find our forward-looking statements and disclosure information. Before we begin, I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results